Skip to main content
Premium Trial:

Request an Annual Quote

Amersham's MegaBace to Assist Brazil's Cancer Fight

Premium

SÃO PAULO--Amersham Pharmacia Biotech's high-throughput DNA sequencing system, MegaBace 1000, was picked recently by the Ludwig Institute for Cancer Research and the State of São Paolo Research Foundation to speed up efforts here to discover cancer-causing genes. The first of its kind in South America, the $10 million project is being funded equally by the research foundation and by the São Paulo branch of the Ludwig Institute, which is based in San Diego.

The project will cover six new Brazilian sequencing centers, including the Ludwig Institute, each of which will use a MegaBace 1000 as part of the endeavor to decode approximately 500,000 sequences of DNA by February 2001.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.